CommercialCoverageMedium impact
Proton Beam Radiation Therapy 6.01.11
Excellus BlueCross BlueShield·Oncology, Radiation Oncology, Neurosurgery +3 more·Radiation Treatment
Effective date
Aug 21, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield updated their proton beam radiation therapy policy, effective August 21, 2025, specifying exact medical conditions and criteria for coverage approval. The policy explicitly states proton beam therapy is NOT covered for prostate cancer, non-small-cell lung cancer, and esophageal cancer, while defining specific covered indications including head/neck cancers, CNS tumors, and pediatric cancers.
Action Required
Before August 21, 2025: Review all pending and future proton beam therapy requests to ensure they meet the specific covered indications listed in policy 6.01.11. Stop approving proton beam therapy for prostate cancer, non-small-cell lung cancer, and esophageal cancer as these are explicitly non-covered. Update prior authorization workflows to verify patients meet detailed criteria for covered conditions (head/neck cancers, CNS tumors, pediatric cancers, genetic syndromes, etc.). Ensure treatment is performed at specialized proton centers only.